A unique BCR–ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study

• Published in: Cancer genetics and cytogenetics 2010-08, Vol.201 (1), p.57-61
• Main Authors: Sadia, Hajra, Siddiqui, Rubina T, Nasim, Anwar
• Format: Article
• Language: English
• Subjects: Acute lymphatic leukemia; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Exons; Genes, abl; Hematology, Oncology and Palliative Medicine; Humans; Introns; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics; Medical Education; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - genetics; Translocation, Genetic
• ISSN: 0165-4608; 1873-4456
• DOI: 10.1016/j.cancergencyto.2010.03.017

Abstract The BCR–ABL1 fusion gene results from a reciprocal translocation rearrangement, t(9;22)(q34;q11.2), and is a hallmark of chronic myeloid leukemia (CML). The breakpoint on chromosome 9 is mostly 5′ to ABL1 exon 2, whereas on chromosome 22, the breakpoint can occur in various regions involving the major breakpoint cluster region (M-bcr) in CML and the minor breakpoint cluster region (m-bcr) in acute lymphoblastic leukemia. Described here is a rare case of Philadelphia-positive CML with intronic splice sites. This atypical BCR–ABL1 transcript was detected along with a classic e13a2 transcript, using reverse transcription polymerase chain reaction (RT-PCR). Nucleotide sequence analysis revealed a joining of BCR intron 13 with ABL1 intron 1a. Both transcripts were detected when the patient was on hydroxyurea treatment; with imatinib mesylate therapy, the atypical transcript disappeared. To our knowledge, this is the first report of BCR–ABL1 transcript with breakpoint occurring within both BCR and ABL1 introns and fusion of intronic sequences from both BCR and ABL1 genes.